Our strategy Our current strategic period started in 2021, setting out our vision and goals to achieve testing for healthy and safe lives.
ACT-Accelerator We co-convene the diagnostics pillar of this global collaboration to ensure access to COVID-19 tests for everyone, everywhere.
Self-testing Self-testing and self-sampling can support equitable access to testing to everyone, regardless of their location or social status.
100 Days Mission A plan for the world to be able to respond to and extinguish the global threat of the next Disease X within 100 days of WHO declaring a major outbreak or pandemic.
Press release FIND and the Helmsley Charitable Trust partner to improve access to continuous glucose self-monitoring devices in Kenya and South Africa
DxConnect Tools and resources provided under the DxConnect umbrella contain information managed and collated – but not owned – by FIND, as a service to the diagnostics community.
Data for decisions Diagnostics provide critical information for healthcare professionals, decision-makers, and people living with diseases and health conditions.
The diagnostic journey From R&D to implementation, the diagnostic value chain can be thought of as a journey of interconnected steps, or a "virtuous cycle".
Diagnostics Commission The Lancet Commission on diagnostics was published in 2021, putting forward recommendations to accelerate and transform access to diagnostics globally.
Press release FIND explores new diagnostic technologies with the potential to confirm hepatitis C infection in community settings FIND 16 Nov 2018
Press release Malaysia takes the lead on a public health approach to hepatitis C with new initiative to enhance diagnosis & treatment FIND 08 Aug 2018
Press release Chembio Diagnostics announces collaboration with FIND to develop hepatitis C virus point-of-care diagnostic test FIND 28 Jul 2018
Press release FIND & DNDi team up to support Malaysian MOH efforts to simplify and decentralize hepatitis C screening & treatment FIND 23 Jul 2018